Negara: Australia
Bahasa: Inggris
Sumber: Department of Health (Therapeutic Goods Administration)
Influenza virus haemagglutinin
Novartis Vaccines & Diagnostics Pty Ltd
Medicine Registered
FLUVIRIN ® CMI FLU_CMI_26Nov2010 Page 1 of 5 CONSUMER MEDICINE INFORMATION FLUVIRIN ® 2011 INACTIVATED INFLUENZA VACCINE (SURFACE ANTIGEN) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Fluvirin ® vaccine. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines, including vaccines, have risks and benefits. Your doctor considers the risks of you or your child having Fluvirin ® vaccine and the benefits he/she expect it will have. IF YOU HAVE ANY CONCERNS ABOUT THIS VACCINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT FLUVIRIN ® VACCINE IS USED FOR Fluvirin ® vaccine helps prevent influenza, often called the flu. Influenza is caused by infection with specific influenza viruses. New types of influenza virus can appear each year. Fluvirin ® vaccine contains strains of three different types of influenza virus. Each year the Australian Influenza Vaccine Committee and the New Zealand Ministry of Health decide which three types of virus are most suitable. Vaccination against influenza helps prevent infection with influenza and to control the spread of the disease. The virus in the vaccine is inactivated. Therefore the vaccine will not give you or your child the flu. Note: the vaccine will not protect you or your child from the other influenza viruses that Fluvirin ® vaccine does not contain. It will not protect you from other types of influenza virus or from infections with other agents causing flu-like symptoms (such as the common cold). Fluvirin ® vaccine is available only with a doctor's prescription. This year (2011) the viruses are A/California/7/2009 (H1N1) Baca dokumen lengkapnya
FLU_PI_26Nov2010 1/5 FLUVIRIN ® 2011 PRODUCT INFORMATION NAME OF THE MEDICINE FLUVIRIN ® [lnactivated Influenza Vaccine (Surface Antigen) Ph. Eur.]. FLUVIRIN ® contains purified haemagglutinin and neuraminidase surface antigens prepared from influenza viruses currently recommended by the Australian Influenza Vaccine Committee (AIVC) DESCRIPTION FLUVIRIN ® [inactivated influenza vaccine (Surface Antigen) Ph. Eur.) is a slightly opalescent, sterile solution for injection. Each 0.5 mL single dose syringe contains 15 micrograms of each of the purified haemagglutinin and neuraminidase antigens prepared from the influenza virus strains currently recommended by the AIVC, which for the 2011 Winter are: A/California/07/2009 (H1N1) – like strain (A/California/07/2009, NYMC X-181); A/Perth/16/2009 (H3N2) – like strain (A/Victoria/210/2009, NYMC X-187); and B/Brisbane/60/2008 – like strain (B/Brisbane/60/2008, NYMC BX-35). The strains chosen for vaccine manufacture are endorsed by the AIVC as being antigenically equivalent to the reference virus. The vaccine contains the following excipients: water for injection, sodium phosphate-dibasic, potassium phosphate-monobasic and sodium chloride. PHARMACOLOGY This vaccine is used for active immunisation against influenza virus, types A and B, principally for the vaccination of those groups regarded as being at special risk, especially the elderly. The vaccine stimulates production of antibodies with a specific capacity against influenza. Any protection is only against those strains of the virus from which the vaccine is prepared or closely related strains. Studies with surface antigen influenza vaccine have shown that the purified haemagglutinin and neuraminidase antigens contained in a single dose of FLUVIRIN ® [inactivated Influenza Vaccine (Surface Antigen) Ph. E Baca dokumen lengkapnya